EVALUATION OF CELLULAR IMMUNE RESPONSE DURING XENOVACCINE THERAPY OF THE PATIENTS WITH STAGE IV OF COLORECTAL CANCER
Abstract. Thirty-seven patients with stage colorectal cancer stage IV were subjected to immunotherapy using a polyantigenic vaccine, prepared, basically, from lyzed cells of murine melanoma (B16) and murine carcinoma (LLC) cells. The inducing course of xenovaccine therapy consisted of 10 subcutaneou...
Main Authors: | M. A. Felde, D. M. Samarin, N. A. Niza, A. A. Shishkov, O. V. Poveshenko, E. A. Kashchenko, V. I. Seledtsov, G. V. Seledtsova, V. A. Kozlov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2014-07-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/433 |
Similar Items
-
HUMORAL AND CELLULAR IMMUNITY FACTORS IN MYOCARDIAL INFARCTION
by: V. I. Seledtsov, et al.
Published: (2014-07-01) -
EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
by: V. V. Kurilin, et al.
Published: (2021-10-01) -
CELL MEDIATED IMMUNITY IN PATIENTS WITH STAGE II–IV COLORECTAL CANCER WITH OR WITHOUT CIRCULATING TUMOR CELLS
by: E. Y. Zlatnik, et al.
Published: (2020-09-01) -
Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer
by: Xiaolin Zhang, et al.
Published: (2021-09-01) -
CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
by: I. P. Ivanova, et al.
Published: (2021-10-01)